FNB:NYSEF.N.B. Corporation Analysis
Data as of 2026-06-14 - not real-time
$18.64
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
F.N.B. Corp. is trading at $18.64, just below the calculated resistance of $18.68 and comfortably above the support level of $16.99, indicating a tight near‑term range. The 14‑day RSI of 68 signals the stock is approaching overbought territory, while a bullish MACD histogram (+0.12) suggests lingering upward momentum. Volume is on an increasing trend, supporting the recent price gains. At a trailing P/E of 11.5, the stock is priced well below the industry average P/E of 16.8, hinting at a value edge, yet the DCF‑derived fair value of $16.96 is beneath the current price, tempering the upside narrative. Revenue growth of 9.6% and an operating margin of 42% underscore solid earnings power, complemented by a 2.79% dividend yield and a modest 29.6% payout ratio, which together point to dividend sustainability. The upside/downside estimate of roughly 10% aligns with the modest upside potential above the resistance level. Volatility over the past 30 days is elevated at 22%, and the beta around 1.0 reflects market‑line sensitivity, adding a moderate risk dimension. Overall, the stock offers a blend of modest growth, attractive valuation relative to peers, and a reliable dividend, but short‑term price pressure near resistance and overbought signals warrant a cautious stance.
Investors looking for a balanced exposure may consider a medium‑term buy, leveraging the undervalued valuation metrics and stable cash flow, while maintaining vigilance on technical overbought cues. For the long haul, the consistent dividend and steady profitability support a hold‑to‑buy recommendation, whereas the immediate term may be best approached with a hold or light trimming until a clearer breakout or pull‑back clarifies direction.
Investors looking for a balanced exposure may consider a medium‑term buy, leveraging the undervalued valuation metrics and stable cash flow, while maintaining vigilance on technical overbought cues. For the long haul, the consistent dividend and steady profitability support a hold‑to‑buy recommendation, whereas the immediate term may be best approached with a hold or light trimming until a clearer breakout or pull‑back clarifies direction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering at resistance with limited upside
- RSI near overbought levels
- Increasing volume but bullish MACD may be fading
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Valuation below industry P/E and P/B benchmarks
- Revenue growth of ~9% and strong operating margins
- Sustainable dividend yield and low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Stable dividend and solid cash flow generation
- Consistent profitability with ROE near 9%
- Balanced risk profile with low geographic and currency exposure
Key Metrics & Analysis
Financial Health
Revenue Growth9.60%
Profit Margin34.08%
P/E Ratio11.5
ROE8.85%
ROA1.17%
P/B Ratio1.0
Op. Cash Flow$569.0M
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI67.9
Support$16.99
Resistance$18.68
MA 20$17.59
MA 50$17.62
MA 200$16.95
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair Value$16.96
Target Price$20.63
Upside/Downside10.65%
GradeFair
TypeBlend
Dividend Yield2.79%
Risk Assessment
Beta1.06
Volatility22.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.